Oxidative stress responses in hepatocarcinogenesis: unravelling the mechanisms using a toxicogenomics approach by Deferme, L.
  
 
Oxidative stress responses in hepatocarcinogenesis:
unravelling the mechanisms using a toxicogenomics
approach
Citation for published version (APA):
Deferme, L. (2015). Oxidative stress responses in hepatocarcinogenesis: unravelling the mechanisms
using a toxicogenomics approach. ‘s-Hertogenbosch: Proefschriftmaken.nl || Uitgeverij BOXPress.
Document status and date:
Published: 01/01/2015
Document Version:
Publisher's PDF, also known as Version of record
Please check the document version of this publication:
• A submitted manuscript is the version of the article upon submission and before peer-review. There can
be important differences between the submitted version and the official published version of record.
People interested in the research are advised to contact the author for the final version of the publication,
or visit the DOI to the publisher's website.
• The final author version and the galley proof are versions of the publication after peer review.
• The final published version features the final layout of the paper including the volume, issue and page
numbers.
Link to publication
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright
owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these
rights.
• Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
• You may not further distribute the material or use it for any profit-making activity or commercial gain
• You may freely distribute the URL identifying the publication in the public portal.
If the publication is distributed under the terms of Article 25fa of the Dutch Copyright Act, indicated by the “Taverne” license above,
please follow below link for the End User Agreement:
www.umlib.nl/taverne-license
Take down policy
If you believe that this document breaches copyright please contact us at:
repository@maastrichtuniversity.nl
providing details and we will investigate your claim.
Download date: 04 Dec. 2019
ADDENDUM 
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Relevance 
The focus of this thesis was on gaining a better insight in the carcinogenic 
impact of oxidant exposure, with particular emphasis on hepatocellular carcinoma 
(HCC) using a human hepatoma cell line (HepG2). HCC is the predominant 
primary malignancy of the liver in most countries. It is the fifth most common 
cancer in men, and seventh among women, and overall the second leading cause 
of cancer related mortality in the world [1]. Together with the millions of estimated 
new cases each year, HCC inflicts a high social but also economic burden. 
Therefore, investing in prevention, early detection and treatment of this disease is 
of major importance.  
Chronic liver disease due to hepatitis B virus (HBV) or hepatitis C virus 
(HCV) accounts for the majority of HCC cases in developing countries, while in 
Western Europe and Northern America other risk factors exist such as lifestyle in 
general (e.g., obesity and diabetes) and exposure to compounds present in the 
environment, drugs or food [1, 2]. Prevention of HBV is possible by vaccination, 
while a HCV vaccine is until today not available but in development. The existence 
and development of such vaccines and the subsequent control of these viral 
infections, predicts a decrease in the rates of HCC, especially in developing 
countries [3]. However, as the contributions of HBV and HCV infections diminish, 
other risk factors present in the environment may become increasingly important as 
drivers of the future HCC incidence worldwide. Although these different inducers of 
HCC have different cellular targets and modes of action, their common feature is 
the formation of oxidative stress [4, 5]. Oxidative stress plays an important role in 
HCC initiation and progression and is even associated with intrinsic drug resistance 
[6]. Moreover, oxidative stress does not only induce mutations in DNA but can also 
induce changes in the DNA methylation status or inflict histone modifications which 
may further contribute to genomic instability and hepatocarcinogenesis [7-11]. 
Already decades ago, it is hypothesized that antioxidants can be used to 
scavenge these reactive oxygen species (ROS) and thus reduce damage. 
However, in large clinical trials [12-15], the effects of antioxidants could not be 
proven, on the contrary, they can even be harmful since ROS are also necessary 
to maintain normal cellular physiology [16]. For that reason, it is necessary to 
increase our understanding on the underlying molecular responses of the 
transcriptome and epigenome towards oxidative stress-induced damage and how 
this can be recognized, by for example specific gene signatures, to improve the risk 
assessment of new and existing chemicals, such as potential carcinogens and 
drugs. 
Target groups 
The knowledge obtained in this thesis can be used for further translational and 
applied research purposes, for instance for developing in vitro tests in the 
V a l o r i s a t i o n  | 175 
 
pharmaceutical, food and chemical industry. These may increase the correctness of 
prediction, since an incorrect prediction of human safety increases the risk of admitting 
dangerous chemicals (in drugs, pesticides, food, etc…) to the market. On the other 
hand, incorrect prediction, due to differences in toxic responses between rodents and 
human, might also lead to the rejection of truly innocent compounds from the market, 
from which consumers can benefit, for instance as a drug or food additive. 
In the pharmaceutical industry, before new drugs proceed into clinical trials, 
preclinical testing is performed, which mostly consists out of long-term animal 
experiments. If a drug does not induce adverse effects in these in vivo animal tests, 
the drug will be tested further in clinical trials using patients and healthy individuals. 
Roughly 20% of all newly developed drugs which precede this far in the pipeline of 
drug development are proven successful and become publically available [17]. This 
complete process of development and approval of drugs may cost up to US $800 
million before they are released onto the market, what makes it a time-and money-
consuming business [18]. Moreover, despite the existing toxicity testing procedures 
of new drugs, some drugs available on the market are identified to be hepatotoxic 
and can even induce HCC (e.g., Bromfenac and Troglitazone). This can be induced 
by active metabolites or the formation of oxidative stress during metabolization of 
specific drugs, which makes hepatotoxicity one of the major reasons for drug 
withdrawal [2]. Also the lack of knowledge in epigenetic processes which can be 
induced by different oxidative stress-inducing compounds can contribute to such 
adverse outcomes in later phases of drug development. Additionally, many drugs are 
pharmacological hepatotoxic (=dose dependent, e.g., Acetaminophen) which are 
unlimitedly available without a doctor’s prescription [19]. This can have tremendous 
effects on population’s health but also have a disastrous effect for a company’s 
credibility and economic status. This indicates that toxicity testing in the 
pharmaceutical industry needs to be improved to reduce the number of falsely 
predicted compounds and subsequent economic and social costs. 
The same applies to the food and chemical industry. Both have to follow 
strict rules and regulations in the development and use of their products to ensure 
human and environmental safety. Risks caused by chemicals (e.g., pesticides, 
metals, …) and food additives (e.g., food dyes, flavor enhancers, nanoparticles, …) 
have to be assessed, managed, and communicated to the customer by correctly 
labeling their products [20]. This process is strictly regulated by initiatives 
developed by the European Union, called REACH (Registration, Evaluation, 
Authorization and Restriction of Chemicals) and OECD (Organization for Economic 
Co-operation and Development) [21, 22]. These authorities apply different 
programs to increase the safety of different chemicals. Because the current in vivo 
toxicity tests for human safety using rodents come along with a financial burden 
and ethical dilemmas, are not high-throughput and are questioned for their 
reliability towards the human situation [23], REACH and OECD also promote the 
development of alternatives for these animal tests. Mechanistic information 
discussed in this thesis can contribute to the development of new toxicity screening 
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methods and, since our results are obtained by in vitro cell models, it can 
contribute to the 3 R’s (Reduction, Refinement and Replacement) in animal testing.  
In general, the knowledge obtained in this thesis can contribute to the 
improvement of the risk assessment of such drugs, chemicals and food additives, 
but can also contribute to a more targeted approach in drug development in 
oxidative stress-driven cancers. By early prediction of toxicity induced via oxidative 
stress and better molecular understanding of this mechanism by compounds 
present in drugs, food and the environment, several future cases of HCC can be 
avoided which will lead to less human suffering and a lower economic burden. 
Activities/products 
Knowledge obtained in this thesis is mainly fundamental and describes 
mechanisms of oxidative stress in the development of HCC that can be used in 
more translational and applied research. Our results can create new opportunities 
for implementation of this knowledge in toxicological screening tests for 
investigating potential harmful or beneficial effects of new chemicals and drugs. In 
addition, compounds already present in the environment or pharmaceutical market 
can be re-evaluated for their oxidative stress-capacities over time which can lead to 
new information of possible hazardous effects for human or other organisms.  
By using extensive time series-analysis for risk evaluation obtained from 
experiments on cell models in combination with transcriptomics and epigenomics, 
alternative approaches for animal studies in risk assessment can be developed. 
This can also service the further enrichment of new analytical tools and statistical 
approaches to make optimal use of the obtained data. Moreover, new treatment 
methods can be developed, since unravelling underlying pathways is the first step 
in the process of new drug development. However, since our knowledge is 
preliminary, more research is needed before applications of our results can be 
used to reduce the economic and social burden of HCC.  
Innovation 
This research focuses on oxidative stress mechanisms in the formation of 
liver toxicity and carcinogenesis. Different ‘omics techniques such as 
transcriptomics and (hydroxy-)methylomics were used in combination with 
detection of phenotypic endpoints such as DNA damage and cell cycle distribution 
changes in order to unravel these specific oxidative stress-related mechanisms 
towards cellular damage. Since such oxidative stress-responses will differ in time, 
we used an innovative temporal analysis to examine time-dependent, sequential 
changes in gene expression and methylation to provide new insights in the 
responses towards oxidant challenge.  
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A combined temporal gene expression profile was identified for menadione 
and TBH exposure. This cluster consists out of 17 co-expressed genes that are 
involved in oxidative stress mechanisms and liver carcinogenesis (BIK, AKR1C2, 
GCLC, GCLM, GSR, LIF, RAP1GAP, SQSTM1, GCNT3, RRAS2, SLC7A11, 
ASF1A, ASKR1B10, FBXO30, AGPAT9, SRXN1, PTGR1). This specific oxidative 
stress related gene expression profile can be applied for a better recognition and 
mechanistic understanding of oxidative stress induced cell damage by chemicals. 
This gene set was used in Chapter 4 to identify genotoxic-, non-genotoxic- and 
non-carcinogens that have the ability to induce oxidative stress. We observed that 
a higher number of upregulated genes is associated with a higher genotoxic 
capacity of the compound. This demonstrates the relevance of this gene list as well 
as the use of time series-analysis to predict oxidative stress-inducing capacities of 
unknown compounds. This temporal gene expression profiles can be further 
developed by testing the expression of these particular genes in liver tissue and 
blood samples of HCC patients. 
In addition, by combining transcriptomic and epigenomic data from the 
whole genome following oxidative stress, we were able to identify a counter-
regulating property of the methylome towards the primary response of the 
transcriptome over time. These results further underline that toxicity screening has 
to be improved by emphasize on time series analysis but also on epigenetic 
responses towards different compounds.  
These findings can eventually open up new doors for prevention and early 
treatment in HCC and possibly other chronic liver diseases. 
Implementation 
Apart from the economic aspect, societal value can be created from 
knowledge obtained in this thesis. Finding out more about the specific underlying 
oxidative stress mechanisms in hepatocarcinogenesis can ultimately lead to better 
prevention and early treatment methods. By using the previously discussed 
temporal gene expression profile as a diagnostic tool, potential patients can be 
screened for HCC in an early stage of disease. If the underlying mechanisms are 
really known, this will also lead to the reduction of side-effects of certain 
treatments, which is again beneficial for the patient.  
As previously discussed, chemical safety is important and increasing the 
safety of compounds in drugs, environment and nutrition is a task of regulatory 
authorities such as the OECD. The OECD has recently launched a new program 
on the generation of Adverse Outcome Pathways (AOP) [24]. A better 
understanding of oxidative stress-related mechanisms of certain compounds can 
facilitate the construction of such AOPs. Possibly, an oxidative stress-specific AOP 
can be implemented in the future. The development of such in vitro tests can 
facilitate the further identification of key events in oxidative stress-related damage 
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induced by certain compounds. This will reduce the amount of laboratory animals, 
economic costs, but especially also the social impact of adverse drug effects that 
can be avoided by a better risk assessments.  
